NEWS AND EVENTS
NEWS AND EVENTS
Biotech innovation in Spain: the European Investment Bank provides €20 million in financing to Sanifit to develop treatments for vascular calcification
The EU bank will support Palma-based Sanifit in its work to develop cutting-edge solutions in biomedical research. The venture debt operation is supported by the Investment Plan for Europe. Palma, Spain and San Diego, USA, 6 August 2020 – The European Investment Bank (EIB) is set to support the development of new treatments […]
Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease
FDA has agreed to key aspects of the clinical program, including the primary endpoint for the single pivotal phase 3 study There are approximately 175,000 and 150,000 ESKD patients with PAD in the USA and Europe respectively with no approved treatments Palma, Spain and San Diego, USA, 20 July 2020 – Sanifit, a clinical-stage biopharmaceutical […]
SNF472 Mechanism of Action data published in British Journal of Pharmacology
SNF472 selectively inhibits pathological calcification by binding to hydroxyapatite crystals Palma, Spain and San Diego, USA, 25 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced that data examining the mechanism of action of SNF472, Sanifit’s lead compound in development, has been published in the British Journal […]
Sanifit Enhances Leadership Team with New Executive Appointments
Newly appointed VP of Business Development and SVP of Clinical Development each bring to Sanifit over 20 years of industry experience Palma, Spain and San Diego, USA, 01 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, is delighted to announce two new appointments to its Executive leadership team, […]
SNF472 featured in AHA Journal’s Circulation on the Run podcast
Dr. Paolo Raggi, Principal Investigator of Sanifit’s Phase 2b CaLIPSO study of SNF472, was recently interviewed by the American Heart Association Journal’s Circulation On The Run podcast team. You can hear Dr Raggi speak about the effect of calcification on patients with end stage renal disease, the significant outcomes of the trial and the next […]
Latest News
UPCOMING EVENTS
17th – 19th November – Jefferies London Healthcare Conference, London, UK.
14th – 16th November – American Heart Association Conference, Dallas, USA.
26th – 28th October – BIO Europe, Munich, Germany
20th – 25th October – ASN Kidney Week, Denver, USA